Cardiac cachexia is a complex and severe condition characterized by the unintended loss of weight, muscle atrophy, and weakness in individuals with chronic heart failure. This condition goes beyond mere weight loss, encompassing a profound depletion of lean body mass and fat stores. It poses a significant challenge in the management of heart failure, often leading to increased morbidity and mortality. The underlying mechanisms of cardiac cachexia involve a complex interplay of inflammation, hormonal imbalance, and metabolic disturbances. Clinically, patients with cardiac cachexia experience a decline in functional capacity and a compromised quality of life. Management strategies typically involve a multidisciplinary approach, focusing on nutritional support, exercise rehabilitation, and addressing the underlying causes of heart failure. Research into the pathophysiology and treatment options for cardiac cachexia is ongoing, aiming to enhance our understanding and improve the prognosis for individuals affected by this debilitating condition.
Title : Novel mechanisms and new therapeutics for right heart failure in pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China